Relamorelin

relamorelin · Motus Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Relamorelin, covering 2016-09-22 to 2021-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 [Phase 3]